Co-crystals and salts of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine
AssigneesAbivax, Centre National De La Recherche Scientifique, Universite De Montpellier, Institut Curie
InventorsJérôme MENEGOTTO, Jérôme DENIS
Life of this patent
Estimating the term…
Abstract
Co-crystals and pharmaceutically acceptable salts and methods for the preparation of the co-crystals and the pharmaceutically acceptable salts of 8-chloro-N-(4-(trifluoromethoxy)phenyl)quinolin-2-amine, pharmaceutical compositions including them as well as their use as medicines and more particularly for use in the prevention and/or treatment of inflammatory diseases, diseases caused by viruses and/or cancer or dysplasia.
Claims18
Co-crystals of 8-chloro-N-(4-(trifluoromethoxy)phenyl)quinolin-2-amine which are chosen among:
- 8-Chloro-N-(4-(trifluoromethoxy)phenyl)quinolin-2-amine:
- L-Proline having a powder X-ray diffractogram displaying peaks expressed as degree 2-Theta angle at 16.5;
- 20.6;
- 21.4;
- and 22.1 (each time ±0.2), and which may optionally further show the following additional peaks expressed as degree 2-Theta angle:
- 11.0;
- 15.9;
- 18.3;
- and 19.4 (each time ±0.2);
- and even optionally further the following additional peaks expressed as degree 2-Theta angle 6.1;
- 12.2;
- 12.6;
- 13.3;
- 13.7;
- 15.4;
- 17.3 and 22.4 (each time ±0.2) and/or having a single endotherm with an onset temperature of 172.0° C. (±2° C.);
- 8-Chloro-N-(4-(trifluoromethoxy)phenyl)quinolin-2-amine:
- Gentisic acid having a powder X-ray diffractogram displaying peaks expressed as degree 2-Theta angle at 7.9;
- 14.0;
- 15.2;
- and 25.2 (each time ±0.2), and which may optionally further show the following additional peaks expressed as degree 2-Theta angle:
- 15.8;
- 16.9;
- 18.5;
- 19.9;
- 20.3;
- 23.0 and 24.7 (each time ±0.2);
- and even optionally further the following additional peaks expressed as degree 2-Theta angle:
- 7.6;
- 14.7;
- 16.1;
- 19.7;
- 21.6;
- 22.0;
- 22.3;
- 23.7;
- and 24.0 (each time ±0.2), and/or having a single endotherm with an onset temperature of 133.0° C. (±2° C.);
- 8-Chloro-N-(4-(trifluoromethoxy)phenyl)quinolin-2-amine:
- Malonic acid having a powder X-ray diffractogram displaying peaks expressed as degree 2-Theta angle at 9.5;
- 12.2;
- 15.8;
- 17.3;
- 19.7;
- 22.8;
- 24.8;
- and 25.6 (each time ±0.2), and which may optionally further show the following additional peaks expressed as degree 2-Theta angle:
- 19.0;
- 21.4;
- 24.6;
- 26.8;
- 27.6;
- and 29.9 (each time ±0.2);
- and even optionally further the following additional peaks expressed as degree 2-Theta angle 16.8;
- 17.8;
- 20.9;
- 23.8;
- 28.0;
- and 29.6 (each time ±0.2), and/or having a single endotherm with an onset temperature of 109.0° C. (±2° C.);
- and
- 8-Chloro-N-(4-(trifluoromethoxy)phenyl)quinolin-2-amine:
- 4, 4′-Bipyridine having a powder X-ray diffractogram displaying peaks expressed as degree 2-Theta angle at 12.0;
- 19.2;
- 21.2;
- and 24.3 (each time ±0.2), and which may optionally further show the following additional peaks expressed as degree 2-Theta angle:
- 16.0;
- 17.0;
- 17.8;
- 20.3;
- 22.5;
- and 22.7 (each time ±0.2);
- and even optionally further the following additional peaks expressed as degree 2-Theta angle:
- 8.5;
- 13.0;
- 15.7;
- 16.7;
- 20.9;
- 22.0;
- 23.1;
- 23.6 and 24.7 (each time ±0.2), and/or having a single endotherm with an onset temperature of 127.0° C. (±2° C.).
A pharmaceutically acceptable salt of 8-chloro-N-(4-(trifluoromethoxy)phenyl)quinolin-2-amine including a solvate and/or a hydrate thereof which is selected from lactate, oleate, oxalate, palmitate, stearate, valerate, pantothenate, picrate, butyrate, malonate, succinate, bitartrate, malate, mandelate, benzoate, edetate, gluceptate, gluconate, lactobionate, salicylate, disalicylate, mucate, pamoate, adipate, alginate, aspartate, camphorate, cyclopentaneproprionate, digluconate, glucoheptonate, heptanoate, hexanoate, laurate, nicotinate, pamoate, pivalate, propionate, undecanoate, phosphate, camphorsulfonate, 2-hydroxy-ethanesulfonate, estolate, napsylate, esylate, napadisylate, dodecylsulfate, perchloric acid, boric acid, glycerophosphoric acid, nitric acid, and persulfuric acid.
Dependencies are inferred from the claim text.